Sonoma Pharmaceuticals, Inc.
SNOA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001367083
No open-market purchases or sales by Sonoma Pharmaceuticals, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $136.3K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Sonoma Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 17 | 1 | 14 | −2 |
| Shares | 67.5K | 1 | 110.8K | +43.3K (+64.2%) |
| Value | $143.7K | $2 | $136.3K | −$7.44K (−5.2%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Sonoma Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 40,468 | $49.8K | 0.00% |
| Global Retirement Partners, LLC | 2,548 | $3.13K | 0.00% |
| Barclays PLC | 459 | $565 | 0.00% |
| Harbour Investments, Inc. | 15 | $18 | 0.00% |
Sold out (6)
Institutions that held Sonoma Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| DRW Securities, LLC | 12,015 | $25.6K |
| Citigroup Inc | 1,425 | $3.04K |
| Tower Research Capital LLC (TRC) | 1,231 | $2.62K |
| JPMorgan Chase & Co | 123 | $255 |
| US Bancorp | 25 | $53 |
| Caitong International Asset Management Co., Ltd | 1 | $2 |
Not filed for Q2 2026 yet (1)
Institutions that held Sonoma Pharmaceuticals, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 1 | $2 |